share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股SEC公告 ·  06/27 17:13
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 06/27/2024, as per the latest filing. The shares, valued at an aggregate market value of $43,290.18, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a recent history of transactions by Marriott Tina, who sold a total of 6,000 shares over the past three months, generating total gross proceeds of $49,345.50.
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 06/27/2024, as per the latest filing. The shares, valued at an aggregate market value of $43,290.18, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a recent history of transactions by Marriott Tina, who sold a total of 6,000 shares over the past three months, generating total gross proceeds of $49,345.50.
根据最新的文件,Recursion Pharmaceuticals, Inc. 的执行官Marriott Tina打算在2024年06月27日卖出6000股A类股份。这些股份的市场总价值为43290.18美元,最初是通过2018年07月23日授予的期权获得的。此次交易将以现金方式进行。在过去的三个月中,Marriott Tina 进行了多次交易,总共卖出了6000股,总毛收入为49345.50美元。
根据最新的文件,Recursion Pharmaceuticals, Inc. 的执行官Marriott Tina打算在2024年06月27日卖出6000股A类股份。这些股份的市场总价值为43290.18美元,最初是通过2018年07月23日授予的期权获得的。此次交易将以现金方式进行。在过去的三个月中,Marriott Tina 进行了多次交易,总共卖出了6000股,总毛收入为49345.50美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息